CRVS - Corvus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

CRVS is currently covered by 5 analysts with an average price target of $32. This is a potential upside of $22.33 (230.92%) from yesterday's end of day stock price of $9.67.

Corvus Pharmaceuticals's activity chart (see below) currently has 65 price targets and 68 ratings on display. The stock rating distribution of CRVS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 86.33% of the time, taking 618.25 days on average.

Highest price target for CRVS is $42, Lowest price target is $27, average price target is $32.

Most recent stock forecast was given by JEFF JONES from OPPENHEIMER on 13-Mar-2026. First documented stock forecast 13-Mar-2017.

Currently out of the existing stock ratings of CRVS, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Aug-2023

$33

$23.33 (241.26%)

$32

8 months 9 days ago
(13-Mar-2026)

9/11 (81.82%)

$17.68 (115.40%)

326

Buy Since 20-May-2025

$30

$20.33 (210.24%)

$20

9 months 24 days ago
(29-Jan-2026)

7/8 (87.5%)

$9.06 (43.27%)

195

Buy Since 01-Dec-2021

$42

$32.33 (334.33%)

$13

10 months ago
(22-Jan-2026)

2/3 (66.67%)

$16.48 (64.58%)

746

Buy Since 13-Oct-2025

$28

$18.33 (189.56%)

$16

10 months 1 days ago
(21-Jan-2026)

1/2 (50%)

$5.85 (26.41%)

99

Buy Since 02-Jan-2025

$27

$17.33 (179.21%)

$11

10 months 2 days ago
(20-Jan-2026)

3/4 (75%)

$5.59 (26.11%)

352

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRVS (Corvus Pharmaceuticals) average time for price targets to be met?

On average it took 618 days for the stock forecasts to be reached, with an average price target met ratio of 86.33%.

Which analyst most recently updated their price target on CRVS (Corvus Pharmaceuticals)?

Jeff Jones

Which analyst has the most public recommendations on CRVS (Corvus Pharmaceuticals)?

Jeff Jones works at OPPENHEIMER and has 5 price targets and 4 ratings on CRVS

Which analyst is the currently most bullish on CRVS (Corvus Pharmaceuticals)?

Roger Song with the highest potential upside of $32.33

Which analyst is the currently most reserved on CRVS (Corvus Pharmaceuticals)?

Mara Goldstein with the lowest potential downside of -$6.17
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?